Malgorzata Mikulska
Overview
Explore the profile of Malgorzata Mikulska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
207
Citations
3451
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ullah N, Muccio M, Magnasco L, Sepulcri C, Giacobbe D, Vena A, et al.
J Fungi (Basel)
. 2025 Feb;
11(2).
PMID: 39997443
Background: 1, 3-ß-D-Glucan (BDG) is an antigen present in the cell wall of many pathogenic fungi and is used as a marker for the early diagnosis of candidemia and discontinuation...
2.
Drozd-Sokolowska J, Tridello G, Verheggen I, Karakukcu M, Ben Abdeljelil N, Colita A, et al.
Bone Marrow Transplant
. 2025 Feb;
PMID: 39994334
Tuberculosis (TB) is rare following hematopoietic cell transplantation (HCT). In this multinational retrospective study, we report the frequency, characteristics, and outcome of TB following HCT performed during 2000-2019. Fifty-two patients...
3.
Cornely O, Sprute R, Bassetti M, Chen S, Groll A, Kurzai O, et al.
Lancet Infect Dis
. 2025 Feb;
PMID: 39956121
Candida species are the predominant cause of fungal infections in patients treated in hospital, contributing substantially to morbidity and mortality. Candidaemia and other forms of invasive candidiasis primarily affect patients...
4.
Cornely O, Dupont H, Mikulska M, Rautemaa-Richardson R, Garcia-Vidal C, Thompson 3rd G, et al.
J Infect
. 2025 Feb;
90(3):106435.
PMID: 39921063
Achieving and maintaining therapeutic drug exposures with antifungals can be challenging in special patient populations, such as those with organ dysfunction (liver or kidney) or obesity, or elderly patients, due...
5.
Ullah N, Fusco L, Ametrano L, Bartalucci C, Giacobbe D, Vena A, et al.
J Clin Med
. 2025 Jan;
14(2).
PMID: 39860395
In immunocompromised patients, pneumonia presents a diagnostic challenge due to diverse etiologies, nonspecific symptoms, overlapping radiological presentation, frequent co-infections, and the potential for rapid progression to severe disease. Thus, timely...
6.
Vena A, Tiseo G, Falcone M, Bartalucci C, Marelli C, Cesaretti M, et al.
Clin Infect Dis
. 2025 Jan;
PMID: 39810592
Background: This study assesses the impact of fluconazole resistance on 30-day all-cause mortality and 1-year recurrence in patients with Candida parapsilosis bloodstream infections (BSI). Methods: A multicenter retrospective study was...
7.
Lombardi A, Grossi P, Mikulska M, Giannella M, Pascale R, Marinello S, et al.
Transpl Infect Dis
. 2025 Jan;
e14413.
PMID: 39791921
Introduction: Infections significantly impact morbidity and mortality in lung transplant (LuTx) recipients. This survey focused on documenting current practices regarding the prevention and management of infections in LuTx in Italy....
8.
Falco-Roget A, Raiola A, Balletto E, Varaldo R, Gambella M, Lanino E, et al.
Bone Marrow Transplant
. 2024 Dec;
60(3):363-372.
PMID: 39663472
Bloodstream infections (BSI) are frequent complications after allogeneic hematopoietic cell transplant (HCT). This study reports data on pre-engraftment BSI in years 2016-2021 and analyses changes in incidence, aetiology, resistance and...
9.
Mularoni A, Cona A, Bulati M, Busa R, Miele M, Timoneri F, et al.
Am J Transplant
. 2024 Nov;
PMID: 39551265
Kaposi sarcoma (KS) herpesvirus/human herpesvirus-8 (HHV-8) neoplastic and nonneoplastic disease in solid organ transplant recipients can be life-threatening. We evaluated the seroprevalence of HHV-8 infection among donors (D) and recipients...
10.
Sepulcri C, Bartalucci C, Mikulska M
Curr Opin Infect Dis
. 2024 Oct;
37(6):506-517.
PMID: 39446756
Purpose Of Review: The purpose of this review is to report the available evidence regarding the use of combination regimens of antivirals and/or antibody-based therapy in the treatment of SARS-CoV-2...